Additional Paid In Capital - Mabwell Shanghai Bioscience Co Ltd (SSE:688062) - Alpha Spread
M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 21.24 CNY -0.28% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Mabwell Shanghai Bioscience Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mabwell Shanghai Bioscience Co Ltd
Additional Paid In Capital Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
M
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Additional Paid In Capital
ÂĄ5.9B
CAGR 3-Years
40%
CAGR 5-Years
106%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Additional Paid In Capital
ÂĄ81.4B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Additional Paid In Capital
ÂĄ27.3B
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Additional Paid In Capital
ÂĄ4.6B
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Additional Paid In Capital
ÂĄ3.3B
CAGR 3-Years
95%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mabwell Shanghai Bioscience Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
5.9B CNY

Based on the financial report for Dec 31, 2023, Mabwell Shanghai Bioscience Co Ltd's Additional Paid In Capital amounts to 5.9B CNY.

What is Mabwell Shanghai Bioscience Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
106%

Over the last year, the Additional Paid In Capital growth was 2%. The average annual Additional Paid In Capital growth rates for Mabwell Shanghai Bioscience Co Ltd have been 40% over the past three years , 106% over the past five years .

Back to Top